These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The role of the fibrinolytic system in deep vein thrombosis. Wiman B; Ljungberg B; Chmielewska J; Urdén G; Blombäck M; Johnsson H J Lab Clin Med; 1985 Feb; 105(2):265-70. PubMed ID: 3919125 [TBL] [Abstract][Full Text] [Related]
45. [Structure, function and use of fibrinolysis-promoting and inhibiting factors]. Bachmann F Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431 [TBL] [Abstract][Full Text] [Related]
47. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039 [TBL] [Abstract][Full Text] [Related]
48. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. Medcalf RL; Van den Berg E; Schleuning WD J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194 [TBL] [Abstract][Full Text] [Related]
49. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction. Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755 [TBL] [Abstract][Full Text] [Related]
50. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Francis RB; McGehee WG; Feinstein DI Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079 [TBL] [Abstract][Full Text] [Related]
51. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Estellés A; Gilabert J; Aznar J; Loskutoff DJ; Schleef RR Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307 [TBL] [Abstract][Full Text] [Related]
52. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. Colucci M; Paramo JA; Collen D J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245 [TBL] [Abstract][Full Text] [Related]
53. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632 [TBL] [Abstract][Full Text] [Related]
54. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147 [TBL] [Abstract][Full Text] [Related]
55. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells. Hu XY; Ma YH; Wang C; Yang YH Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143 [TBL] [Abstract][Full Text] [Related]
56. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164 [TBL] [Abstract][Full Text] [Related]
57. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Smith FB; Lee AJ; Rumley A; Fowkes FG; Lowe GD Atherosclerosis; 1995 May; 115(1):35-43. PubMed ID: 7669086 [TBL] [Abstract][Full Text] [Related]
58. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
59. Tissue plasminogen activator and its inhibitor following major surgery in relation to ventilatory pattern. Eriksson E; Risberg B Acta Chir Scand; 1988 Jan; 154(1):57-60. PubMed ID: 3128033 [TBL] [Abstract][Full Text] [Related]
60. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. Hamsten A; Wiman B; de Faire U; Blombäck M N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]